Search
Refine your search
737 results found
Smart & Biggar | Canada | 19 Feb 2020
PMPRB reports upward trend of high-cost drugs
In January 2020 the Patented Medicine Prices Review Board released the Meds Entry Watch 2018, which analyses information about medicines approved by
Smart & Biggar | Canada | 13 Feb 2020
The Best of the Decade - Canadian Patent Law in the 2010s
The 2010s saw many developments in Canadian patent law. Establishment of a trade agreement with the European Union, ratification of an international
Smart & Biggar | Canada | 12 Feb 2020
Canadian Institute for Health Information publishes drug spending statistics
The Canadian Institute for Health Information recently published statistics on drug spending, finding that in 2018 approximately 40 of drug spending
Smart & Biggar | Canada | 11 Feb 2020
A Step Towards Canadian Ratification of "NAFTA 2.1"
Bill C-4, entitled An Act to implement the Agreement between Canada, the United States of America and the United Mexican States was tabled in the
Smart & Biggar | USA, Canada | 10 Feb 2020
Trademarks Office issues new limits on time extensions to respond to office actions
Prior to 17 January 2020, time extensions were readily available during Canadian trademark prosecution. A single six-month extension could be secured
Smart & Biggar | Canada | 31 Jan 2020
Federal Court maintains $100M award in cefaclor infringement damages reconsideration decision
On November 20, 2019, the Federal Court (FC) issued its reconsideration decision on the quantum of damages owed by Apotex for its infringement of
Smart & Biggar | Canada | 29 Jan 2020
Life sciences intellectual property: 2019 highlights
There have been a number of key developments in Canadian life sciences IP and regulatory law over the past 12 months, including significant amendments
Smart & Biggar | USA, Canada | 27 Jan 2020
USMCA amendments: implications for Canadian IP law
On 10 December 2019 the United States, Mexico and Canada signed the Protocol of Amendment to the Agreement between the United States of America, the
Smart & Biggar | Canada | 20 Jan 2020
Federal Court dismisses patent infringement action for delay
In Sikes v Encana Corporation (Court File T-1345-13), the Federal Court dismissed an action for delay following a status review under Section 382.1
Smart & Biggar | Canada | 20 Jan 2020
Canadian Trademarks Office issues new limits on extensions of time for responding to office actions
Prior to January 17, 2020, extensions of time were readily available during Canadian trademark prosecution. A single six-month extension could be
